NO309767B1 - Ny form av (E)-3-[6-[[(2,6-diklorfenyl)-tio]metyl]-3-(2- fenyletoksy)-2-pyridinyl]-2-propensyre, anvendelse derav og farmasöytisk blanding inneholdende den - Google Patents
Ny form av (E)-3-[6-[[(2,6-diklorfenyl)-tio]metyl]-3-(2- fenyletoksy)-2-pyridinyl]-2-propensyre, anvendelse derav og farmasöytisk blanding inneholdende den Download PDFInfo
- Publication number
- NO309767B1 NO309767B1 NO974840A NO974840A NO309767B1 NO 309767 B1 NO309767 B1 NO 309767B1 NO 974840 A NO974840 A NO 974840A NO 974840 A NO974840 A NO 974840A NO 309767 B1 NO309767 B1 NO 309767B1
- Authority
- NO
- Norway
- Prior art keywords
- phenylethoxy
- dichlorophenyl
- pyridinyl
- thio
- methyl
- Prior art date
Links
- ZJLFOOWTDISDIO-ZRDIBKRKSA-N (e)-3-[6-[(2,6-dichlorophenyl)sulfanylmethyl]-3-(2-phenylethoxy)pyridin-2-yl]prop-2-enoic acid Chemical compound C=1C=C(OCCC=2C=CC=CC=2)C(/C=C/C(=O)O)=NC=1CSC1=C(Cl)C=CC=C1Cl ZJLFOOWTDISDIO-ZRDIBKRKSA-N 0.000 title claims abstract description 22
- 239000008194 pharmaceutical composition Substances 0.000 title description 4
- 150000001875 compounds Chemical class 0.000 claims description 9
- 201000004681 Psoriasis Diseases 0.000 claims description 7
- 238000010521 absorption reaction Methods 0.000 claims description 7
- 238000002441 X-ray diffraction Methods 0.000 claims description 6
- 238000000113 differential scanning calorimetry Methods 0.000 claims description 6
- 238000002844 melting Methods 0.000 claims description 6
- 230000008018 melting Effects 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 4
- 239000003937 drug carrier Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 abstract description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- -1 2,6-dichlorophenyl Chemical group 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 229910052724 xenon Inorganic materials 0.000 description 2
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 125000001995 cyclobutyl group Chemical class [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000012049 topical pharmaceutical composition Substances 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000759 toxicological effect Toxicity 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/32—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9508137.8A GB9508137D0 (en) | 1995-04-21 | 1995-04-21 | Formulation |
| PCT/EP1996/001466 WO1996033174A1 (en) | 1995-04-21 | 1996-04-02 | New form of (e)-3-[6-[[(2,6-dichlorophenyl)-thio]methyl]-3-(2-phenylethoxy)-2-pyridinyl]-2-propenoic acid |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO974840D0 NO974840D0 (no) | 1997-10-20 |
| NO974840L NO974840L (no) | 1997-10-20 |
| NO309767B1 true NO309767B1 (no) | 2001-03-26 |
Family
ID=10773317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO974840A NO309767B1 (no) | 1995-04-21 | 1997-10-20 | Ny form av (E)-3-[6-[[(2,6-diklorfenyl)-tio]metyl]-3-(2- fenyletoksy)-2-pyridinyl]-2-propensyre, anvendelse derav og farmasöytisk blanding inneholdende den |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6093828A (pt) |
| EP (1) | EP0821673B1 (pt) |
| JP (1) | JPH11503737A (pt) |
| KR (1) | KR19990007900A (pt) |
| CN (1) | CN1182418A (pt) |
| AT (1) | ATE198883T1 (pt) |
| AU (1) | AU707089B2 (pt) |
| BR (1) | BR9608003A (pt) |
| CA (1) | CA2218322A1 (pt) |
| CZ (1) | CZ333797A3 (pt) |
| DE (1) | DE69611670T2 (pt) |
| DK (1) | DK0821673T3 (pt) |
| ES (1) | ES2154818T3 (pt) |
| GB (1) | GB9508137D0 (pt) |
| GR (1) | GR3035494T3 (pt) |
| HU (1) | HUP9801574A3 (pt) |
| NO (1) | NO309767B1 (pt) |
| NZ (1) | NZ307493A (pt) |
| PL (1) | PL322897A1 (pt) |
| PT (1) | PT821673E (pt) |
| TR (1) | TR199701213T1 (pt) |
| WO (1) | WO1996033174A1 (pt) |
| ZA (1) | ZA963134B (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9602675D0 (en) * | 1996-02-09 | 1996-04-10 | Smithkline Beecham Plc | Process |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0604529A1 (en) * | 1991-09-19 | 1994-07-06 | Smithkline Beecham Corporation | Pyridine compounds for treating leukotriene-related diseases |
| IL106156A0 (en) * | 1992-06-30 | 1993-10-20 | Smithkline Beecham Corp | Pyridinyl compounds |
| CN1095713A (zh) * | 1992-06-30 | 1994-11-30 | 史密丝克莱恩比彻姆公司 | 制造某些硫醚的方法 |
| GB9313145D0 (en) * | 1993-06-25 | 1993-08-11 | Smithkline Beecham Plc | Process |
-
1995
- 1995-04-21 GB GBGB9508137.8A patent/GB9508137D0/en active Pending
-
1996
- 1996-04-02 NZ NZ307493A patent/NZ307493A/en unknown
- 1996-04-02 KR KR1019970707423A patent/KR19990007900A/ko not_active Application Discontinuation
- 1996-04-02 DE DE69611670T patent/DE69611670T2/de not_active Expired - Fee Related
- 1996-04-02 ES ES96914877T patent/ES2154818T3/es not_active Expired - Lifetime
- 1996-04-02 US US08/945,372 patent/US6093828A/en not_active Expired - Fee Related
- 1996-04-02 PT PT96914877T patent/PT821673E/pt unknown
- 1996-04-02 BR BR9608003A patent/BR9608003A/pt active Search and Examination
- 1996-04-02 WO PCT/EP1996/001466 patent/WO1996033174A1/en not_active Application Discontinuation
- 1996-04-02 CA CA002218322A patent/CA2218322A1/en not_active Abandoned
- 1996-04-02 CZ CZ973337A patent/CZ333797A3/cs unknown
- 1996-04-02 PL PL96322897A patent/PL322897A1/xx unknown
- 1996-04-02 DK DK96914877T patent/DK0821673T3/da active
- 1996-04-02 HU HU9801574A patent/HUP9801574A3/hu unknown
- 1996-04-02 CN CN96193405A patent/CN1182418A/zh active Pending
- 1996-04-02 EP EP96914877A patent/EP0821673B1/en not_active Expired - Lifetime
- 1996-04-02 JP JP8531444A patent/JPH11503737A/ja active Pending
- 1996-04-02 AU AU56859/96A patent/AU707089B2/en not_active Ceased
- 1996-04-02 AT AT96914877T patent/ATE198883T1/de active
- 1996-04-02 TR TR97/01213T patent/TR199701213T1/xx unknown
- 1996-04-19 ZA ZA9603134A patent/ZA963134B/xx unknown
-
1997
- 1997-10-20 NO NO974840A patent/NO309767B1/no not_active IP Right Cessation
-
2001
- 2001-02-28 GR GR20010400337T patent/GR3035494T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP9801574A2 (hu) | 1998-11-30 |
| AU5685996A (en) | 1996-11-07 |
| NO974840D0 (no) | 1997-10-20 |
| ES2154818T3 (es) | 2001-04-16 |
| HUP9801574A3 (en) | 1998-12-28 |
| ATE198883T1 (de) | 2001-02-15 |
| BR9608003A (pt) | 1999-01-05 |
| NZ307493A (en) | 1998-07-28 |
| PL322897A1 (en) | 1998-03-02 |
| NO974840L (no) | 1997-10-20 |
| KR19990007900A (ko) | 1999-01-25 |
| CA2218322A1 (en) | 1996-10-24 |
| US6093828A (en) | 2000-07-25 |
| GB9508137D0 (en) | 1995-06-07 |
| WO1996033174A1 (en) | 1996-10-24 |
| GR3035494T3 (en) | 2001-05-31 |
| ZA963134B (en) | 1997-02-14 |
| TR199701213T1 (pt) | 1998-03-21 |
| EP0821673B1 (en) | 2001-01-24 |
| DE69611670D1 (en) | 2001-03-01 |
| DK0821673T3 (da) | 2001-06-18 |
| AU707089B2 (en) | 1999-07-01 |
| CZ333797A3 (cs) | 1999-01-13 |
| EP0821673A1 (en) | 1998-02-04 |
| JPH11503737A (ja) | 1999-03-30 |
| DE69611670T2 (de) | 2001-08-23 |
| CN1182418A (zh) | 1998-05-20 |
| PT821673E (pt) | 2001-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5736377B2 (ja) | １−クロロ−４−（β−Ｄ−グルコピラノス−１−イル）−２−［４−（（Ｓ）−テトラヒドロフラン−３−イルオキシ）ベンジル］ベンゼンの結晶形の調製方法 | |
| EP0258755B1 (en) | Alpha-alkyl-4-amino-3-quinoline-methanols and 1-(4-aralkylamino-3-quinolinyl) alkanones, a process for their preparation and their use as medicaments | |
| SK167698A3 (en) | Polymorphs of donepezil hydrochloride and process for production | |
| US5354760A (en) | Crystalline Tiagabine monohydrate, its preparation and use | |
| DE3318989C2 (de) | ß,gamma-Dihydropolyprenylalkoholderivate und diese enthaltende Arzneimittel und deren Verwendung | |
| US6518288B2 (en) | Amlodipine fumarate | |
| NO155490B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktivt 4-)1"-hydroksy-2"-(n-imidazolyl)etyl)bibenzyl. | |
| SK302003A3 (en) | Stable gabapentin having pH within a controlled range | |
| US6538012B2 (en) | Amlodipine hemimaleate | |
| NO309767B1 (no) | Ny form av (E)-3-[6-[[(2,6-diklorfenyl)-tio]metyl]-3-(2- fenyletoksy)-2-pyridinyl]-2-propensyre, anvendelse derav og farmasöytisk blanding inneholdende den | |
| CA1132983A (fr) | Procedes de preparation de nouvelles piperazines monosubstituees | |
| US4840972A (en) | Relief from memory dysfunction with α-alkyl-4-amino-3-quinolinemethanols and 1-(4-aralkylamino-3-quinolinyl)alkanones and related compounds | |
| EP2057130A2 (en) | Improved method for synthesizing lamotrigine | |
| NO312587B1 (no) | Fremgangsmåte for fremstilling av 1-butyl-4-piperidinyl- metylamin | |
| LU82115A1 (fr) | Nouvelles quinazolines anti-hypertensives,leur procede de production et composition pharmaceutique les contenant | |
| US5434165A (en) | Nootropic agents, compositions of, and method of use thereof | |
| AU2001100436A4 (en) | Amlodipine hemimaleate | |
| HU211635A9 (en) | Pharmaceutically useful bicyclolactam derivative | |
| AU2001100435A4 (en) | Amlodipine fumarate | |
| EP0251858A1 (fr) | N-imidazolylméthyl-diphénylazo-méthines, leur préparation et leur application en thérapeutique | |
| JPH06239742A (ja) | 排尿障害の予防・治療剤 | |
| JPS60246365A (ja) | プロリン誘導体 | |
| MXPA97008089A (en) | Compound | |
| FR2532846A1 (fr) | Composition pharmaceutique comprenant a titre de principe actif le 3,7,11,15 - tetramethyl -1,6,10,14-hexadecatetraene-3-ol | |
| GB2336840A (en) | Tilidine embonate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN OCTOBER 2002 |